Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | Alenphosome-alendronate lipid nanoparticle (neutral) |
| Catalog Number | LPs-019 |
| Size | 10 mg; 20 mg; 50 mg |
| Alias | Alenphosome-alendronate LNP (neutral); Alendronate sodium nanodelivery system |
| Appearance | Milky white homogeneous suspension |
| Solubility | It can be dispersed in physiological buffer or sterile PBS to form a stable colloidal dispersion system |
| Description | Alenphosome-alendronate lipid nanoparticles are neutral-charge liposomes encapsulating the bisphosphonate drug alendronate for bone-targeted delivery research. The neutral PEGylated surface minimizes non-specific protein binding and prolongs circulation, while alendronate's inherent hydroxyapatite affinity guides bone tissue targeting. Used for bone microenvironment-specific drug delivery studies. |
| Applications | Bone microenvironment-specific drug delivery |
| Storage | 4°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 Year |
| Shipping Condition | Low temperature transport |